Horm Metab Res 2001; 33(1): 1-6
DOI: 10.1055/s-2001-12617
Original Basic
© Georg Thieme Verlag Stuttgart · New York

Leptin Mediates a Proliferative Response in Human Gastric Mucosa Cells with Functional Receptor

R. Schneider1 , S. R. Bornstein2 , G. P. Chrousos2 , S. Boxberger1 , G. Ehninger1 , M. Breidert1
  • 1 Medical Department I, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany
  • 2 Developmental Endocrinology Branch, National Institute of Health and Human Development, National Institutes of Health, Bethesda, MD, USA
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Background: Recently, the rat stomach was reported as a source of leptin, a hormone mainly secreted by adipocytes. Also Helicobacter pylori-induced gastritis in humans was associated with locally elevated leptin levels. In addition, it was suggested that gastric leptin adjusts the function of the intestinal tract in parallel to the function of hypothalamic satiety centers. Aims: Here we examined the synthesis and potential physiologic role of leptin in the human stomach. Methods: RT-PCR was employed to detect leptin mRNA in the human stomach and the human gastric carcinoma cell line AGS while immunogold staining and electron microscopy were used to detect leptin protein. The in vitro effects of leptin on cell proliferation were examined in the AGS cell line. Results: No leptin mRNA could be detected by RT-PCR, yet immunogold labeling and electron microscopy allowed visualization of leptin protein in the human gastric mucosa. At concentrations of 100 nM, leptin led to a significantly increased BrdU-uptake in AGS cells (+ 27 %, p < 0.017). The MAP-kinase-1-specific inhibitor U0126 blocked the leptin-induced cell proliferation in a dose-dependent fashion. Conclusions: Leptin protein may not be produced but rather stored in human gastric cells. Leptin-induced increases in the proliferation of gastric mucosa cells suggests that leptin might contribute to mucosal integrity and gastroprotection.

References

  • 1 Flier J S. What's in a name? In search of leptins' physiologic role.  J Clin Endocrinol Metab. 1998;  83 1407-1413
  • 2 Halaas J L, Gajiwala K S, Maffei M, Cohen S C, Chait D T, Rabinowitz D. Weight reducing effects of the plasma protein encoded by the obese gene.  Science. 1995;  269 543-546
  • 3 Stephens T W, Basinski M, Bristow P K. The role of neuropeptide Y in the antiobesity action of the ob aene product.  Nature. 1995;  377 530-532
  • 4 Considine R V, Sinha N W, Heiman N M, Kriauciunas A, Stephens T W, Nyce M R, Ohannesian J P, Marco C C, McKee L J, Bauer T L, Caro J F. Serum immunoreactive-leptin concentrations in normal-weight and obese humans.  N Engl J Med. 1996;  334 292-295
  • 5 Takahashi Y, Okimura Y, Mizuno I, lida K, Takahashi T, Kaji H, Abe H, Chihara K. Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H1OT1/2 cells.  J Biol Chem. 1997;  272 12 897-12 900
  • 6 Islam S, Morton N M, Hansson A, Emilsson V. Rat insulinoma-derived pancreatic β-cells express a functional leptin receptor that mediates a proliferative response.  Biochem Biophys Res Com. 1997;  238 851-855
  • 7 Tsuchiya T, Shimizu H, Horie T, Mori M. Expression of leptin receptor in lung: leptin as a growth factor.  Eur J Pharm. 1999;  365 273-279
  • 8 Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau J P, Bortoluzzi M N, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, Lewin M JM. The stomach is a source of leptin.  Nature. 1998;  394 790-793
  • 9 Breidert M, Miehlke S, Glasow A, Orban Z, Stolte M, Ehninger G, Bayerdörffer E, Nettesheim 0, Halm U, Haidan A, Bornstein S R. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis.  Scand J Gastroenterol. 1999;  34 954-961
  • 10 Ballinger A. Gastric leptin.  Gut. 1999;  44 153-154
  • 11 Wang Y H, Tache Y, Sheibel A B, Go V LW, Wie J Y. Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats.  Am J Physiol. 1997;  273 R833-R837
  • 12 Smith P M, Mollaret V, Ferguson A V. Leptin acts in the rat hypothalamic paraventricular nucleus to induce gastric mucosal damage.  Am J Physiol. 1998;  275 R2081-R2084
  • 13 Kaplan L M. Leptin, obesity, and liver disease.  Gastroenterology. 1998;  115 997-1001
  • 14 Aiston S, Agious L. Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin.  Diabetes. 1998;  48 15-20
  • 15 Lord G M, Matarese G, Howard J K, Baker R J, Bloom S R, Lechler R I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.  Nature. 1998;  394 897-901
  • 16 Wolf G, Hamann A, Han D C, Helmchen U, Thaiss F, Ziyadeh F N, Stahl R AK. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis.  Kidney International. 1998;  56 860-872
  • 17 Faggioni R, Fantuzzi G, Fuller J, Dinarello C A, Feingold K R, Grunfeld C. IL-1 beta mediates leptin induction during inflammation.  Am J Physiol. 1998;  274 R204-R208
  • 18 Sarraf P, Frederich R C, Turner E M. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.  Exp Med. 1997;  185 171-175
  • 19 Torpy D J, Bornstein S R, Chrousos G P. Leptin and interleukin-6 in sepsis.  Horm Metab Res. 1998;  30 726-729
  • 20 Akira S. IL-6-regulated transcription factors.  Int J Biochem Cell Biol. 1997;  29 1401-1418
  • 21 Vaisse C, Halaas J L, Horvath C M, Darnell J E Jr, Stoffel M, Friedman J M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.  Nat Genet. 1996;  14 95-97
  • 22 Dignass A U, Tsunekawa S, Podolsky D K. Fibroblast growth factors modulate intestinal epithelial cell growth and migration.  Gastroenterology. 1994;  106 1254-1262
  • 23 Brzozowski T, Konturek P C, Konturek S J, Pajdo R, Duda A, Pierzchalski P, Bielanski W, Hahn E G. Leptin in gastroprotection induced by cholecystokinin or by meal. Role of vagal and sensory nerves and nitric oxide.  Eur J Pharm. 1999;  374 263-276
  • 24 Potten C S, Owen G, Hewitt D, Chadwick C A, Hendry H, Lord B I, Woolford L B. Small intestinal crypts of the mouse after in vivo administration of growth factors.  Gut. 1995;  36 864-873

M. Breidert,M.D. 

Medical Department I
University Hospital Carl Gustav Carus
Technical University Dresden

Fetscherstrasse 74
01307 Dresden
Germany


Phone: Phone:+ 49 (351) 4584259

Fax: Fax:+ 49 (351) 4584394

Email: E-mail:breidert@rcs.urz.tu-dresden.de